Identiv Reports Second Quarter 2025 Financial Results
Completed Transfer of Production from
"In the second quarter, we made important progress across all three pillars of our Perform-Accelerate-Transform (P-A-T) strategy. We believe our customers clearly see the value
Financial Results for Fiscal Second Quarter 2025
Revenue for the second quarter of 2025 was
Second quarter 2025 GAAP gross margin was (9.4%) and non-GAAP gross margin was (0.8%), compared to second quarter 2024 GAAP gross margin of 9.1% and non-GAAP gross margin of 14.6%. The year-over-year decrease was primarily driven by the incremental costs related to the transition of production to
GAAP operating expenses, including research and development, selling and marketing, general and administrative, and restructuring and severance, were
Second quarter 2025 GAAP net loss from continuing operations was
Non-GAAP adjusted EBITDA loss in the second quarter of 2025 was
Chief Financial Officer Transition
Effective
Financial Outlook
Conference Call
Toll-Free: +1 888-506-0062
International Number: +1 973-528-0011
Call ID: 725308
Webcast link: Register and Join
The teleconference replay will be available through
If you have any difficulty connecting with the teleconference, please contact Identiv Investor Relations at IR@identiv.com.
About
Non-GAAP Financial Measures
This press release includes financial information that has not been prepared in accordance with accounting principles generally accepted in
Note Regarding Forward-Looking Information
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are those involving future events and future results that are based on current expectations as well as the current beliefs and assumptions of management of
Investor Relations Contact:
IR@identiv.com
Media Contact:
press@identiv.com
|
|||||||
Condensed Consolidated Statements of Operations |
|||||||
(in thousands, except per share data) |
|||||||
(unaudited) |
|||||||
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
||||
|
|
|
|
|
|
|
|
|
2025 |
|
2024 |
|
2025 |
|
2024 |
Net revenue |
$ 5,040 |
|
$ 6,741 |
|
$ 10,309 |
|
$ 13,399 |
Cost of revenue |
5,514 |
|
6,127 |
|
10,651 |
|
12,302 |
Gross profit (loss) |
(474) |
|
614 |
|
(342) |
|
1,097 |
Operating expenses: |
|
|
|
|
|
|
|
Research and development |
890 |
|
966 |
|
1,677 |
|
1,863 |
Selling and marketing |
1,546 |
|
1,828 |
|
2,953 |
|
2,997 |
General and administrative |
3,057 |
|
4,540 |
|
6,203 |
|
8,020 |
Restructuring and severance |
420 |
|
— |
|
680 |
|
- |
Total operating expenses |
5,913 |
|
7,334 |
|
11,513 |
|
12,880 |
Loss from continuing operations |
(6,387) |
|
(6,720) |
|
(11,855) |
|
(11,783) |
Non-operating income (expense): |
|
|
|
|
|
|
|
Interest income (expense), net |
1,320 |
|
(149) |
|
2,532 |
|
(236) |
Foreign currency losses, net |
(870) |
|
(59) |
|
(1,400) |
|
(285) |
Loss from continuing operations before income tax benefit (provision) |
(5,937) |
|
(6,928) |
|
(10,723) |
|
(12,304) |
Income tax benefit (provision) |
(105) |
|
5 |
|
(108) |
|
(1) |
Net loss from continuing operations |
(6,042) |
|
(6,923) |
|
(10,831) |
|
(12,305) |
Income from discontinued operations, net of tax |
— |
|
707 |
|
— |
|
1,531 |
Net loss |
(6,042) |
|
(6,216) |
|
(10,831) |
|
(10,774) |
Cumulative dividends on Series B convertible preferred stock |
(205) |
|
(233) |
|
(410) |
|
(481) |
Net loss available to common stockholders |
$ (6,247) |
|
$ (6,449) |
|
$ (11,241) |
|
$ (11,255) |
|
|
|
|
|
|
|
|
Net income (loss) per common share: |
|
|
|
|
|
|
|
Basic and diluted - continuing operations |
$ (0.26) |
|
$ (0.31) |
|
$ (0.47) |
|
$ (0.55) |
Basic and diluted - discontinued operations |
$ — |
|
$ 0.03 |
|
$ — |
|
$ 0.07 |
Basic and diluted - net loss |
$ (0.26) |
|
$ (0.27) |
|
$ (0.47) |
|
$ (0.48) |
|
|
|
|
|
|
|
|
Weighted average common shares outstanding: |
|
|
|
|
|
|
|
Basic and diluted |
23,760 |
|
23,459 |
|
23,679 |
|
23,413 |
|
|||
Condensed Consolidated Balance Sheets |
|||
(in thousands) |
|||
(unaudited) |
|||
|
|
|
|
|
|
|
|
|
2025 |
|
2024 |
|
|
|
|
ASSETS |
|
|
|
Current assets: |
|
|
|
Cash and cash equivalents |
$ 129,339 |
|
$ 135,646 |
Restricted cash |
300 |
|
300 |
Accounts receivable, net of allowances |
3,466 |
|
4,214 |
Inventories |
6,133 |
|
7,475 |
Prepaid expenses and other current assets |
4,874 |
|
5,210 |
Total current assets |
144,112 |
|
152,845 |
Property and equipment, net |
7,526 |
|
7,694 |
Operating lease right-of-use assets |
1,395 |
|
2,000 |
Other assets |
843 |
|
686 |
Total assets |
$ 153,876 |
|
$ 163,225 |
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
Current liabilities: |
|
|
|
Accounts payable |
$ 1,809 |
|
$ 2,746 |
Operating lease liabilities |
895 |
|
852 |
Accrued compensation and related benefits |
792 |
|
862 |
Accrued income taxes payable |
1,223 |
|
1,173 |
Other accrued expenses and liabilities |
1,923 |
|
2,327 |
Total current liabilities |
6,642 |
|
7,960 |
Long-term operating lease liabilities |
790 |
|
1,167 |
Other long-term liabilities |
29 |
|
29 |
Total liabilities |
7,461 |
|
9,156 |
Total stockholders' equity |
146,415 |
|
154,069 |
Total liabilities and stockholders' equity |
$ 153,876 |
|
$ 163,225 |
|
|||||||
Reconciliation of GAAP to Non-GAAP Financial Information - Continuing Operations |
|||||||
(in thousands) |
|||||||
(unaudited) |
|||||||
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
||||
|
|
|
|
|
|
|
|
|
2025 |
|
2024 |
|
2025 |
|
2024 |
Reconciliation of GAAP gross margin to non-GAAP gross margin |
|
|
|
|
|
|
|
GAAP gross profit (loss) |
$ (474) |
|
$ 614 |
|
$ (342) |
|
$ 1,097 |
Reconciling items included in GAAP gross profit (loss): |
|
|
|
|
|
|
|
Stock-based compensation |
5 |
|
5 |
|
10 |
|
12 |
Amortization and depreciation |
428 |
|
364 |
|
862 |
|
768 |
Total reconciling items included in GAAP gross profit (loss) |
433 |
|
369 |
|
872 |
|
780 |
Non-GAAP gross profit (loss) |
$ (41) |
|
$ 983 |
|
$ 530 |
|
$ 1,877 |
Non-GAAP gross margin |
(0.8 %) |
|
14.6 % |
|
5.1 % |
|
14.0 % |
|
|
|
|
|
|
|
|
Reconciliation of GAAP operating expenses to non-GAAP operating expenses |
|
|
|
|
|
|
|
GAAP operating expenses |
$ 5,913 |
|
$ 7,334 |
|
$ 11,513 |
|
$ 12,880 |
Reconciling items included in GAAP operating expenses: |
|
|
|
|
|
|
|
Stock-based compensation |
(902) |
|
(980) |
|
(1,693) |
|
(1,492) |
Amortization and depreciation |
(61) |
|
(65) |
|
(118) |
|
(90) |
Strategic review-related costs |
— |
|
(1,616) |
|
(4) |
|
(2,569) |
Restructuring and severance |
(420) |
|
— |
|
(680) |
|
— |
Total reconciling items included in GAAP operating expenses |
(1,383) |
|
(2,661) |
|
(2,495) |
|
(4,151) |
Non-GAAP operating expenses |
$ 4,530 |
|
$ 4,673 |
|
$ 9,018 |
|
$ 8,729 |
|
|
|
|
|
|
|
|
Reconciliation of GAAP net loss from continuing operations to non-GAAP adjusted EBITDA |
|
|
|
|
|
|
|
GAAP net loss |
$ (6,042) |
|
$ (6,923) |
|
$ (10,831) |
|
$ (12,305) |
Reconciling items included in GAAP net loss: |
|
|
|
|
|
|
|
Income tax provision (benefit) |
105 |
|
(5) |
|
108 |
|
1 |
Interest expense (income), net |
(1,320) |
|
149 |
|
(2,532) |
|
236 |
Foreign currency losses, net |
870 |
|
59 |
|
1,400 |
|
285 |
Stock-based compensation |
907 |
|
986 |
|
1,703 |
|
1,504 |
Amortization and depreciation |
489 |
|
429 |
|
980 |
|
858 |
Strategic review-related costs |
— |
|
1,616 |
|
4 |
|
2,569 |
Restructuring and severance |
420 |
|
— |
|
680 |
|
— |
Total reconciling items included in GAAP net loss from continuing operations |
1,471 |
|
3,234 |
|
2,343 |
|
5,453 |
Non-GAAP adjusted EBITDA |
$ (4,571) |
|
$ (3,689) |
|
$ (8,488) |
|
$ (6,852) |
View original content to download multimedia:https://www.prnewswire.com/news-releases/identiv-reports-second-quarter-2025-financial-results-302524762.html
SOURCE